05/22/2020
This is the response I got from my Congressman after emailing my concerns about the FDA's plans for homeopathic remedies. We are being heard. ONE MORE DAY, if you have not responded, please do. You do not even have to write anything personal, just submit the pre-written form letter provided in the link. This can mean a world of difference to everyone being able to choose how they want their medical care to go...suppression of symptoms with drugs, or strengthening and healing the body with homeopathic treatment...
JACK BERGMAN
1ST DISTRICT, MICHIGAN
Congress of the United States // House of Representatives // Washington, DC 20515
COMMITTEE ON ARMED SERVICES
COMMITTEE ON VETERANS' AFFAIRS
May 22, 2020
Dear Dr. Melling:
Thank you for contacting me with your concerns regarding the United States Food and Drug Administration's (FDA) proposed guidance on unregulated homeopathic products. It is an honor to serve the people of Northern Michigan and the Upper Peninsula, and I appreciate your thoughts on this important matter.
The FDA issued a revised draft of its guidance on homeopathic drugs in October 2019 to better define the agency's position on those products. This guidance does not establish any legally enforceable responsibilities and is only intended to make suggestions or recommendations. Included in it is the FDA's recognition of homeopathic drug products as those labeled by the manufacturer as "homeopathic," and contains only active ingredients and dilutions listed in the Homeopathic Pharmacopeia of the United States. Additionally, the FDA anticipates many homeopathic drugs will fall outside its regulatory scope, which, combined with the non-binding nature of the guidance document, should not restrict patients' access to homeopathic remedies.
Homeopathic remedies can afford patients effective alternative treatments when conventional methods have failed. However, we must also ensure manufacturers are held accountable to consumers for the safety and efficacy of their products. As your Representative, one of my top priorities is the wellbeing and health of our communities, and I will continue to advance sound, evidence-based legislation addressing access to safe homeopathic remedies. If you would like to submit your comments to the FDA as well, you may do so at https://beta.regulations.gov until January 23, 2020. Please know I will keep your thoughts on this issue in mind should Congress consider any legislation regarding the FDA and its approach towards homeopathic medicines.
Again, thank you for contacting me about this important issue. It is an honor to represent you in the U.S. House of Representatives, and I am here to help in any way possible. Please do not hesitate to call if I may ever be of service. I look forward to hearing from you again soon.
Kind regards,
(signed)
Jack Bergman
Member of Congress